Bank of New York Mellon Corp - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 51 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$25,000
-35.9%
145,3810.0%0.00%
Q2 2022$39,000
-52.4%
145,381
-0.6%
0.00%
Q1 2022$82,000
-20.4%
146,2910.0%0.00%
Q4 2021$103,000
-16.9%
146,291
+92.2%
0.00%
Q3 2021$124,000
+416.7%
76,122
+537.6%
0.00%
Q2 2021$24,000
-89.9%
11,939
-83.3%
0.00%
Q1 2021$237,000
-16.8%
71,282
-0.4%
0.00%
Q4 2020$285,000
+44.7%
71,568
-4.5%
0.00%
Q3 2020$197,000
+0.5%
74,979
+15.6%
0.00%
Q2 2020$196,000
+46.3%
64,842
-5.5%
0.00%
Q1 2020$134,000
-73.5%
68,6510.0%0.00%
Q4 2019$505,000
+74.1%
68,651
+7.0%
0.00%
Q3 2019$290,000
-53.5%
64,185
+2.6%
0.00%
Q2 2019$624,000
-23.7%
62,572
-10.6%
0.00%
Q1 2019$818,000
+1.5%
70,008
+4.3%
0.00%
Q4 2018$806,000
-25.3%
67,111
+6.0%
0.00%
Q3 2018$1,079,000
+3.9%
63,311
+4.1%
0.00%
Q2 2018$1,038,00060,8150.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 375,000$3,739,0001.40%
CVI Holdings, LLC 223,140$2,226,0000.86%
MENORA MIVTACHIM HOLDINGS LTD. 2,202,456$21,958,0000.59%
Ion Asset Management Ltd. 225,000$2,243,0000.57%
Altshuler Shaham Ltd 1,093,859$11,343,0000.48%
MEITAV INVESTMENT HOUSE LTD 500,436$4,987,0000.33%
Clal Insurance Enterprises Holdings Ltd 595,000$5,932,0000.14%
New England Private Wealth Advisors LLC 50,000$499,0000.12%
EMERALD MUTUAL FUND ADVISERS TRUST 200,000$1,994,0000.08%
ING GROEP NV 30,000$299,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders